The nuclear translocation of TRIM22 is related to the proliferation of GBM cells, but many other signaling pathway (mTOR, JAK2/STAT3, NF-κB/JNK) inhibitors can also affect the nuclear translocation of TRIM22 to some extent. Here, NFKB1 is linked to glioblastoma.